Nuanyang Health closes Pre-A financing round, raises tens of millions of yuan

Nuanyang Health has garnered tens of millions of yuan in a Pre-A financing round jointly invested by China Growth Capital and Rongan Venture Capital. Ruiling Capital served as the sole financial advisor.

Nuanyang Health has garnered tens of millions of yuan in a Pre-A financing round jointly invested by China Growth Capital and Rongan Venture Capital. Ruiling Capital served as the sole financial advisor.

Established in January 2019, Nuanyang Health is a Chinese neurointerventional treatment device manufacturer. The company develops, produces, and sells neurointerventional/implantation devices and accessories through minimally invasive interventional implantation methods, covering two major areas of stroke disease namely ischemic and hemorrhagic.

To date, Nuanyang Health has so far completed the design and development of its first product, and gradually started product type inspection and animal testing as well as new product development.

The members of Nuanyang Health core team have more than ten years of experience in medical device design and development. The company’s R&D center is located in Shanghai Zhangjiang Science and Technology City, and its production base is located in Jiangsu Nantong Science and Technology City.

The company has 1,000 square meters of independent workshops, 10,000-level clean workshops, strong and professional manufacturing capabilities, with a production capacity of up to 300,000 units.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/02/nuanyang-health-closes-pre-a-financing-round-raises-tens-of-millions-of-yuan/.

Leave a Reply

Please Login to Comment